CRISPR and CRISPR-Associated (Cas) Genes Market – Global Outlook and Forecast 2022-2028

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of “spacer DNA” from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell’s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS’s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
This report contains market size and forecasts of CRISPR and CRISPR-Associated (Cas) Genes in Global, including the following market information:
Global CRISPR and CRISPR-Associated (Cas) Genes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CRISPR and CRISPR-Associated (Cas) Genes market was valued at 1424.5 million in 2021 and is projected to reach US$ 9195.8 million by 2028, at a CAGR of 30.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genome Editing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CRISPR and CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich and Precision Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the CRISPR and CRISPR-Associated (Cas) Genes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR and CRISPR-Associated (Cas) Genes Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, by Type, 2021 (%)
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Global CRISPR and CRISPR-Associated (Cas) Genes Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, by Application, 2021 (%)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Global CRISPR and CRISPR-Associated (Cas) Genes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR and CRISPR-Associated (Cas) Genes revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CRISPR and CRISPR-Associated (Cas) Genes revenues share in global market, 2021 (%)
Further, the